Cat. No.: DIA-0231022
Product Information | |
---|---|
CAS No. | 1159824-67-5 |
Formula | C15H17FN6O2S |
Molecular Weight | 364.4 |
SMILES | CC(C)(C)N[S](=O)(=O)C1=CN=CC(=C1)C2=C[N]3N=C(N)N=C3C(=C2)F |
Target | PI3Kγ |
Product Description | CZC24832 is the first selective PI3Kγ inhibitor with IC50 of 27 nM, with 10-fold selectivity over PI3Kβ and >100-fold selectivity over PI3Kα and PI3Kδ. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.